Linn Stefan C 4
4 · Oxford Immunotec Global PLC · Filed Aug 30, 2017
Insider Transaction Report
Form 4
Linn Stefan C
Chief Operating Officer
Transactions
- Award
Ordinary Shares
2017-08-28+32,531→ 32,531 total - Award
Share Option (Right to Buy)
2017-08-28+71,942→ 71,942 totalExercise: $15.37Exp: 2027-08-28→ Ordinary Shares (71,942 underlying)
Footnotes (2)
- [F1]Option granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from September 1, 2018 through September 1, 2021.